인간 간 모델 시장은 2021년 2억 3390만 달러에서 2028년 5억 826만 달러에 이를 것으로 예상됩니다. 2021년부터 2028년까지 CAGR 11.7%로 성장할 것으로 예상됩니다.
시장의 성장은 주로 간 질환의 유병률 증가와 동물 실험 모델의 대안 개발에 대한 관심 증가에 기인합니다. 그러나 인간 간 모델의 높은 비용과 간 모델을 기존 워크플로우에 통합하는 문제는 인간 간 모델 시장의 성장을 방해하고 있습니다. 간은 혈액 응고 인자의 합성, 담즙 생산, 단백질 생산, 해독 작용과 같은 중요한 신체 기능을 수행하는 중요한 기관입니다. 인간 간 모델은 약물의 독성을 연구하고 약물의 효과와 간 질환의 진행을 이해하는 데 사용됩니다. 동물 실험 모델의 대안 개발에 대한 관심이 높아지는 것은 향후 몇 년 동안 전 세계 인간 간 모델의 성장을 촉진할 것으로 예상되는 주요 요인 중 하나입니다.
전략적 통찰력
아시아 태평양 바이오 제약 산업은 COVID-19 발생으로 인해 2020년 몇 달 동안 혼란을 겪었습니다. COVID-19 전염병은 감염 확산을 통제하기 위해 부과된 여러 수준의 제한으로 인해 유례없는 방식으로 임상 시험에 영향을 미쳤습니다. 그러나 COVID-19 감염 치료 제품에 대한 수요가 증가함에 따라 인도와 중국의 바이오 제약 및 제약 회사가 연구 활동을 늘려 시장 성장에 긍정적인 영향을 미치고 있습니다.
인간을 위한 수익성 있는 지역 간 모델 시장
시장 통찰력
간 질환의 유병률 증가로 인간 간 모델 시장 성장 촉진
간은 인체에서 가장 큰 내장 기관이며 기능을 수행합니다. 500개 이상의 기능. 간 독성은 간이 대부분의 제노바이오틱스 화합물과 그 생체 활성 대사 산물에 노출되어 화학적으로 유발된 간 질환에 취약하기 때문에 위험 평가에서 주요 관심사입니다. C형 간염 바이러스(HCV), 만성 B형 간염 바이러스(HBV), 비알코올성 지방간 질환(NAFLD) 및 알코올 관련 간 질환(ALD)은 만성 간 질환의 주요 원인 중 하나입니다. 바이러스성 간염은 계속해서 간부전으로 인한 사망 사례의 주요 원인이며, 동시에 NAFLD는 간 이환율 및 관련 사망률에 가장 빠르게 성장하는 원인 중 하나가 되었습니다. 영국의 국가 통계에 따르면 간 질환은 국내 사망 원인 5위를 차지했습니다.
또한 이러한 질병은 영국의 모든 소화기 질환 중 사망 원인 2위로 간주됩니다. 미국. 미국간질환연구협회(American Association for the Study of Liver Diseases)에 따르면 2017년에 간암과 간경변증의 세계적 부담이 증가했습니다. NAFLD는 일반 인구에서 약 25%의 유병률을 보입니다. 미국 인구의 거의 3분의 1이 NAFLD를 가지고 있으며 제2형 당뇨병 또는 비만 환자는 불균형적으로 영향을 받습니다. NAFLD 환자의 수는 2015년 8,310만 명에서 2030년까지 1억 90만 명으로 증가할 것으로 예상됩니다. 따라서 만성 및 급성 질환과 미생물 감염을 포함한 간 질환의 세계적인 유병률 증가로 간 모델에 대한 수요가 증가합니다.
유형 기반 통찰력
인간 간 모델 시장은 유형에 따라 간 오가노이드, 간 칩, 2D 모델, 3D 바이오프린팅 등으로 세분화됩니다. . 간 오가노이드 부문은 시장에서 가장 큰 점유율을 차지하고 있습니다. 그러나 간 칩 부문은 2021-2028년 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다. 간 오가노이드 기술의 발전은 태아 발달, 조직 보존 및 병리를 위한 모델을 제공하며, 이는 향후 이 부문의 시장 성장을 촉진할 것입니다.
인간 간 모델 시장, 유형별 – 2021 및 2028 < /h3> 응용 기반 통찰력
응용 프로그램을 기반으로 인간 간 모델 시장은 교육, 약물 발견 등으로 세분화됩니다. 약물 발견 부문은 인간 간 모델 시장에서 가장 큰 비중을 차지합니다. 그러나 교육 부문은 예측 기간 동안 가장 높은 CAGR을 기록할 것으로 예상됩니다.
최종 사용자 기반 통찰력
최종 사용자를 기반으로 인간 간 모델 시장은 연구로 분류됩니다. 연구소, 제약 및 생명 공학 회사 및 기타. 제약 및 생명 공학 회사 부문은 가장 큰 시장 점유율을 보유하고 있습니다. 그러나 연구 기관 부문은 예측 기간 동안 가장 높은 CAGR을 등록한 것으로 추정됩니다. 이 부문의 예상되는 시장 성장은 게놈 연구를 위한 산업계와 대학 간의 협력 증가와 인간 간 모델 생산의 기술 발전에 기인할 수 있습니다.
인간 간 모델 시장은 전 세계적으로 진화하는 고객 요구를 충족하기 위해 제품 혁신 전략을 채택하고 있으며 이를 통해 글로벌 시장에서 브랜드 이름을 유지할 수 있습니다.
인간 간 모델 시장 - 유형별
- 간 오가노이드
- 간 칩
- 2D 모델
- 3D 바이오프린팅
- 기타
인간 간 모델 시장 - 애플리케이션별
- 약물 발견
- 교육용
- 기타
- 제약 및 생명공학 회사
- 연구 기관
- 기타
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 프랑스
- 독일
- 이탈리아
- 영국
- 스페인
- 기타 유럽
- 아시아 태평양(APAC)
- 중국
- 인도
- 대한민국
- 일본
- 호주
- 기타 APAC
- 중동 및 아프리카(MEA)
- 남아프리카
- 사우디아라비아
- UAE
- 나머지 MEA
- 중남미(SCAM)
- 브라질
- 아르헨티나
- 나머지 SCAM
- THERMO FISHER SCIENTIFIC INC.
- Emulate, Inc.
- CN Bio Innovations,
- CYFUSE BIOMEDICAL KK
- MIMETAS BV
- InSphero
- BioIVT
- CELLINK
- Kerafast
- Kirkstall
- ORGANOVO HOLDINGS INC
인간 간 모델 시장 – 최종 사용자별
인간 간 모델 시장 – 지역별
회사 프로필
< li>Cyprio
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The factors that are driving growth of the market are increasing prevalence of liver diseases, and growing focus on developing alternatives for animal testing models.
Various companies have made organic growth strategies in the human liver models market. Some of the activities undertaken by the company, which have promoted its growth are, launches, enhancements and expansion & relocation activities. Companies such as InSphero, Emulate, Inc amongst others are some of the companies that have been implementing various organic strategies that have helped the growth of the company.
North America dominates the global human liver models market due to factors such as increasing incidences of the liver diseases such as cirrhosis, chronic liver disease (CLD), Nonalcoholic fatty liver disease (NAFLD) and others across the country. Moreover, the growth of market in Canada is expected to grow due to increasing support from the government to address the rising concerns about the liver diseases.
The liver-on-a-chip segment is growing at the highest CAGR owing to increasing demand for cost-effective alternatives to animal models for drug research and development.
Asia Pacific is expected to be the fastest growing region in the Human Liver Models market. The growth of the market in this region is primarily due to growing biopharmaceutical industry, increasing number of clinical trials, and increasing research activities for the development of innovative therapies.
The List of Companies - Human Liver Models Market
- THERMO FISHER SCIENTIFIC INC.
- Emulate, Inc.
- CN Bio Innovations,
- CYFUSE BIOMEDICAL K.K.
- MIMETAS BV
- InSphero
- BioIVT
- CELLINK
- Kerafast
- Cyprio
- Kirkstall
- ORGANOVO HOLDINGS INC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Oct 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Oct 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Oct 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Oct 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)